ReviewCureus2026
Outcomes and Safety of Same-Day Discharge Following Minimally Invasive Abdominal Surgery: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Same-day discharge (SDD) following minimally invasive abdominal surgery has emerged as a paradigm shift in perioperative care, aiming to enhance patient comfort and optimize healthcare efficiency. This systematic review evaluates the safety and outcomes of SDD after minimally invasive abdominal procedures. A comprehensive literature search was conducted using PubMed, Google Scholar, and the Cochrane Library for studies published between January 2015 and December 2025. The quality of randomized controlled trials and non-randomized studies was assessed using the Cochrane Risk of Bias 2.0 tool and the ROBINS-I tool, respectively, with visual summaries generated using RobVis. A total of 12 studies were included, covering procedures such as colectomy, hysterectomy, bariatric surgery, appendectomy, and cholecystectomy. The primary outcomes assessed were 30-day readmission, postoperative complications, reoperations, mortality, and ED visits. The findings indicate that, with appropriate patient selection, structured discharge planning, and adequate follow-up, SDD is a safe and effective approach. Reported readmission rates ranged from 3% to 7%, while major complication rates were low (0.9-5%). Thirty-day mortality was rare, ranging from 0% to 1% across the included studies. Post-discharge challenges such as pain, nausea, and wound complications highlight the necessity of a structured Enhanced Recovery After Surgery-based perioperative care pathway that extends beyond discharge planning to encompass all aspects of patient management. Overall, SDD appears to be a safe and feasible strategy for carefully selected patients undergoing minimally invasive abdominal surgery without increasing the risk of adverse outcomes. Successful implementation depends on strict patient selection criteria, effective perioperative planning, and robust post-discharge follow-up systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.